top of page
Our Mission
Although mosaic embryo transfer is currently offered as an option for women who undergo IVF, several concerns remain, especially regarding clinical outcomes of mosaic embryos. We aim to increase the currently limited data surrounding mosaic embryo transfer by collecting prospective and retrospective data on mosaic embryo transfer and its prenatal and postnatal outcome. We also hope to promote the formulation of an evidence-based priority scheme for mosaic embryos in the clinic. Finally, we strive to provide guidance and networking opportunities to PGT centres.
Our Plan
Our Team
Dr. Manuel Viotti
Founder
Dr. Francesca Spinella
Founder
Dr. Svetlana Madjunkova
Founder
Andria G. Besser
Founder
Awards & Recognition
First Prize
American Society of Reproductive Medicine (ASRM) Congress 2023 New Orleans, LA
Prize Paper Award
Society of Reproductive Biologists & Technologists (SRBT), 2022
New York Times, April 2021
Article highlighting our study on 1,000 mosaic embryo transfers:
https://www.nytimes.com/2021/04/06/well/family/in-vitro-fertilization-mosaic-embryo.html
Prize Paper Session
American Society of Reproductive Medicine (ASRM) Virtual Congress 2020
bottom of page